Xiangxue Pharmaceutical (300147) — Cash Flow-to-Debt Ratio
Xiangxue Pharmaceutical (300147) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥75.64 Million could theoretically repay 0% of its total liabilities (CN¥6.27 Billion) in one year. See 300147 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xiangxue Pharmaceutical Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Xiangxue Pharmaceutical across 19 annual periods. Also explore Xiangxue Pharmaceutical (300147) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Xiangxue Pharmaceutical (2007–2025)
Year-by-year debt coverage analysis for Xiangxue Pharmaceutical. For market capitalisation and broader financial context, see Xiangxue Pharmaceutical market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥139.63 Million | CN¥6.70 Billion | ▲ +594.7% |
| 2024 | 0.00x | CN¥18.17 Million | CN¥6.06 Billion | ▼ -93.2% |
| 2023 | 0.04x | CN¥263.44 Million | CN¥5.97 Billion | ▲ +26.9% |
| 2022 | 0.03x | CN¥227.38 Million | CN¥6.53 Billion | ▲ +3.0% |
| 2021 | 0.03x | CN¥257.56 Million | CN¥7.62 Billion | ▼ -27.4% |
| 2020 | 0.05x | CN¥257.18 Million | CN¥5.53 Billion | ▲ +143.9% |
| 2019 | 0.02x | CN¥83.02 Million | CN¥4.35 Billion | ▼ -3.5% |
| 2018 | 0.02x | CN¥91.24 Million | CN¥4.61 Billion | ▲ +0.3% |
| 2017 | 0.02x | CN¥109.53 Million | CN¥5.56 Billion | ▼ -57.3% |
| 2016 | 0.05x | CN¥198.48 Million | CN¥4.30 Billion | ▼ -68.1% |
| 2015 | 0.14x | CN¥159.89 Million | CN¥1.11 Billion | ▲ +49.9% |
| 2014 | 0.10x | CN¥165.58 Million | CN¥1.72 Billion | ▼ -48.2% |
| 2013 | 0.19x | CN¥328.37 Million | CN¥1.76 Billion | ▲ +121.0% |
| 2012 | 0.08x | CN¥118.91 Million | CN¥1.41 Billion | ▲ +43.0% |
| 2011 | 0.06x | CN¥29.55 Million | CN¥502.16 Million | ▼ -38.4% |
| 2010 | 0.10x | CN¥45.47 Million | CN¥476.01 Million | ▼ -25.4% |
| 2009 | 0.13x | CN¥46.19 Million | CN¥360.69 Million | ▼ -18.4% |
| 2008 | 0.16x | CN¥55.72 Million | CN¥354.94 Million | ▼ -58.8% |
| 2007 | 0.38x | CN¥138.02 Million | CN¥361.98 Million | — |